TY - JOUR
T1 - Clinical characteristics of septo-optic dysplasia accompanied by congenital central hypothyroidism in Japan
AU - Nagasaki, Keisuke
AU - Kubota, Takuo
AU - Kobayashi, Hironori
AU - Sawada, Hirotake
AU - Numakura, Chikahiko
AU - Harada, Shohei
AU - Takasawa, Kei
AU - Minamitani, Kanshi
AU - Ishii, Tomohiro
AU - Okada, Satoshi
AU - Kamasaki, Hotaka
AU - Sugihara, Shigetaka
AU - Adachi, Masanori
AU - Tajima, Toshihiro
N1 - Funding Information:
This study was partially supported by the Health and Labour Sciences Research Grants, Research on Intractable Diseases, Research Committee on Septo-Optic Dysplasia of the Ministry of Health, Labour, and Welfare, Japan (H27-7).
Publisher Copyright:
© 2017 by The Japanese Society for Pediatric Endocrinology.
PY - 2017
Y1 - 2017
N2 - Septo-optic dysplasia (SOD) is a congenital anomaly in which agenesis of the septum pellucidum and optic nerve hypoplasia are accompanied by hypopituitarism. Typically, the symptoms develop in 3 organs, the brain, eyes, and pituitary, and approximately one third of the patients present with all of the three cardinal features. The diagnostic criteria for SOD were established in Japan in 2015. The purpose of this study is to review clinical features regarding SOD patients with hypopituitarism in Japan. In this study, 21 patients with SOD were identified by a questionnaire survey for congenital central hypothyroidism. All 3 symptoms of SOD, agenesis of the septum pellucidum, optic nerve hypoplasia, and endocrine abnormalities, were noted in 8 of the 21 patients. Various combinations of pituitary hormone deficiencies were observed in patients with SOD, although SOD is a rare, heterogeneous, and phenotypically variable disorder, some patients develop hypoglycemia and convulsions after birth, and early intervention with hormone replacement is necessary in severe cases. In addition, 14 cases were complicated by both developmental delay and epilepsy, and 16 cases involved eye abnormalities. Therefore, in addition to an early endocrinological diagnosis and hormone replacement, consultation with both pediatric neurologists and pediatric ophthalmologists is necessary.
AB - Septo-optic dysplasia (SOD) is a congenital anomaly in which agenesis of the septum pellucidum and optic nerve hypoplasia are accompanied by hypopituitarism. Typically, the symptoms develop in 3 organs, the brain, eyes, and pituitary, and approximately one third of the patients present with all of the three cardinal features. The diagnostic criteria for SOD were established in Japan in 2015. The purpose of this study is to review clinical features regarding SOD patients with hypopituitarism in Japan. In this study, 21 patients with SOD were identified by a questionnaire survey for congenital central hypothyroidism. All 3 symptoms of SOD, agenesis of the septum pellucidum, optic nerve hypoplasia, and endocrine abnormalities, were noted in 8 of the 21 patients. Various combinations of pituitary hormone deficiencies were observed in patients with SOD, although SOD is a rare, heterogeneous, and phenotypically variable disorder, some patients develop hypoglycemia and convulsions after birth, and early intervention with hormone replacement is necessary in severe cases. In addition, 14 cases were complicated by both developmental delay and epilepsy, and 16 cases involved eye abnormalities. Therefore, in addition to an early endocrinological diagnosis and hormone replacement, consultation with both pediatric neurologists and pediatric ophthalmologists is necessary.
KW - Agenesis of the septum pellucidum
KW - Combined pituitary hormone deficiency
KW - Congenital central hypothyroidism
KW - Optic nerve hypoplasia
KW - Septo-optic dysplasia
UR - http://www.scopus.com/inward/record.url?scp=85030215837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030215837&partnerID=8YFLogxK
U2 - 10.1297/cpe.26.207
DO - 10.1297/cpe.26.207
M3 - Article
AN - SCOPUS:85030215837
SN - 0918-5739
VL - 26
SP - 207
EP - 213
JO - clinical pediatric endocrinology
JF - clinical pediatric endocrinology
IS - 4
ER -